These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2078928)

  • 1. Mineral metabolism in CAPD.
    Hamdy NA; Brown CB; Boletis J; Boyle G; Tindale W; Beneton MN; Charlesworth D; Kanis JA
    Contrib Nephrol; 1990; 85():100-10. PubMed ID: 2078928
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of mineral metabolism in CAPD patients.
    Delmez JA
    Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous ambulatory peritoneal dialysis and bone.
    Delmez JA; Fallon MD; Bergfeld MA; Gearing BK; Dougan CS; Teitelbaum SL
    Kidney Int; 1986 Sep; 30(3):379-84. PubMed ID: 3784281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
    Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years].
    Dratwa M; Wens R; Collart F; Tielemans C
    Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis.
    El Shahat Y; Jacobs C; Issad B; Rottembourg J; Legrain M
    Adv Exp Med Biol; 1982; 151():429-40. PubMed ID: 7180661
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
    Aloni Y; Shany S; Chaimovitz C
    Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients.
    Sugimoto T; Yamakado M; Matsushita K; Iwamoto T; Tagawa H
    J Int Med Res; 2002; 30(6):566-75. PubMed ID: 12526283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A; Costanini S; Ballanti P; Castiglioni A; Caligara F; Pisoni B; Giordano R; Vernillo I; Berni S; Bonucci E
    Adv Perit Dial; 1992; 8():351-5. PubMed ID: 1361821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis and vitamin D.
    Rapoport J; Shany S; Chaimovitz C
    Nephron; 1988; 48(1):1-3. PubMed ID: 3277074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent advances in continuous ambulatory peritoneal dialysis].
    Maiorca R; Cancarini GC; Brasa S; Manili L
    Minerva Urol Nefrol; 1985; 37(1):13-21. PubMed ID: 3901334
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minerals and bone-modulating hormones in children on continuous ambulatory peritoneal dialysis.
    Freundlich M; Zilleruelo G; Abitbol C; Hwang KH; Bourgoignie JJ; Strauss J
    Nephron; 1985; 41(3):267-72. PubMed ID: 3840576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.